Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update.

Related Articles

Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update.

Clin Lab Med. 2018 Jun;38(2):357-365

Authors: Zulfiqar M, Bluth MH, Bhalla A

Abstract
Esophageal cancer (EC) is rapidly increasing in incidence in the United States. Genetic changes associated with the development of EC involve the p16, p53, and APC genes. Human epidermal growth factor 2 (HER-2) overexpression is seen in gastroesophageal junction carcinoma and a subset gastric carcinoma (GC). Interestingly, up to 50% cases of GC are related to Helicobacter pylori infection and up to 16% are related to EBV infection. Microsatellite instability is observed in up to 39% of GC and cell free nucleic acid analysis provides additional opportunities for diagnosis and prognosis of disease.

PMID: 29776635 [PubMed – in process]

Be the first to comment

Leave a Reply

Your email address will not be published.


*